• 1
    Arakelov A, Lakkis FG. The alloimmune response and effector mechanisms of allograft rejection. Semin. Nephrol 2000; 20: 95102.
  • 2
    Sprent J, Schaefer M, Lo D, Korngold R. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J Exp Med 1986; 163: 9981011.
  • 3
    Valujskikh A, Matesic D, Heeger PS. Characterization and manipulation of T cell immunity to skin grafts expressing a transgenic minor antigen. Transplantation 1999; 68: 10291036.
  • 4
    Roopenian D. What are minor histocompatibility loci? A new look at an old question. Immunol Today 1992; 13: 710.
  • 5
    Rosenberg A, Singer A. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1992; 10: 333358.
  • 6
    Rees MA, Rosenberg AS, Munitz TI, Singer A. In vivo induction of antigen-specific transplantation tolerance to Qa1a by exposure to alloantigen in the absence of T-cell help. Proc Natl Acad Sci U S A 1990; 87: 27652769.
  • 7
    Wettstein PJ, Korngold R. T cell subsets required for in vivo and in vitro responses to single and multiple minor histocompatibility antigens. Transplantation 1992; 54s: 296307.
  • 8
    Roopenian DC, Davis AP, Christianson GJ, Mobraaten LE. The functional basis of minor histocompatibility loci. J Immunol 1993; 151: 45954605.
  • 9
    Antoniou A, McCormick D, Scott D et al. T cell tolerance and activation to a transgene-encoded tumor antigen. Eur J Immunol 1996; 26: 10941102.
  • 10
    Cardin RD, Brooks JW, Sarawar SR, Doherty PC. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med 1996; 184: 863871.
  • 11
    Matloubian M, Concepcion RJ, Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 1994; 68: 80568063.
  • 12
    Ossendorp F, Mengede E, Camps M, Filius R, Melief CJ. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J Exp Med 1998; 187: 693702.
  • 13
    Simpson E, Scott D, James E et al. Minor H antigens: genes and peptides. Transpl Immunol 2002; 10: 115123.
  • 14
    Ehl S, Aichele P, Ramseier H et al. Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection. Nat Med 1998; 4: 10151019.
  • 15
    Gilot BJ, Hara M, Jones ND et al. Visualization of the in vivo generation of donor antigen-specific effector CD8+ T cells during mouse cardiac allograft rejection: in vivo effector CD8+ T cell generation during allograft rejection. Transplantation 2000; 69: 639648.
  • 16
    Delfs MW, Furukawa Y, Mitchell RN, Lichtman AH. CD8+ T cell subsets TC1 and TC2 cause different histopathologic forms of murine cardiac allograft rejection. Transplantation 2001; 71: 606610.
  • 17
    Choi EY, Yoshimura Y, Christianson GJ et al. Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others. J Immunol 2001; 166: 43704379.
  • 18
    Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell 1994; 76: 1727.
  • 19
    Barnden MJ, Allison J, Heath WR, Carbone FR. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 1998; 76: 3440.
  • 20
    Moore MW, Carbone FR, Bevan MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988; 54: 777785.
  • 21
    Weiss E, Golden L, Zakut R et al. The DNA sequence of the H-2Kb gene: evidence for gene conversion as a mechanism for the generation of polymorphism in histocompatibility antigens. EMBO J 1983; 2: 453462.
  • 22
    Joly E, Oldstone MBA. Manufacture of a functional cDNA for the H-2Db molecule using a retroviral shuttle vector. Immunogenetics 1991; 34: 6265.
  • 23
    Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108: 193199.
  • 24
    Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. Visualizing the generation of memory CD4 T cells in the whole body. Nature 2001; 410: 101105.
  • 25
    Ambrose HW, Ambrose KP. A Handbook of Biological Investigation, 4th edn. Winston, Salem : Hunter Textbooks Inc., 1987.
  • 26
    Jameson SC, Bevan MJ. Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur J Immunol 1992; 22: 26632667.
  • 27
    McReynolds L, O'Malley BW, Nisbet AD et al. Sequence of chicken ovalbumin mRNA. Nature 1978; 273: 723728.
  • 28
    Porgador A, Yewdell JW, Deng Y, Bennink JR, Germain RN. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 1997; 6: 715726.
  • 29
    Bevan MJ. The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. J Exp Med 1975; 142: 13491364.
  • 30
    Gordon RD, Simpson E, Samelson LE. In vitro cell-mediated immune responses to the male specific (H-Y) antigen in mice. J Exp Med 1975; 142: 11081120.
  • 31
    McHeyzer-Williams MG, Davis MM. Antigen-specific development of primary and memory T cells in vivo. Science 1995; 268: 106111.
  • 32
    Busch DH, Pilip IM, Vijh S, Pamer EG. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998; 8: 353362.
  • 33
    Murali-Krishna K, Altman JD, Suresh M et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998; 8: 177187.
  • 34
    Graff RJ, Hildemann WH, Snell GD. Histocompatibility genes of mice. VI. Allografts in mice congenic at various non-H-2 histocompatibility loci. Transplantation 1966; 4: 425437.
  • 35
    Wettstein PJ, Jewett L, Faas S, Brinster RL, Knowles BB. SV40 T-antigen is a histocompatibility antigen of SV40-transgenic mice. Immunogenetics 1988; 27: 436441.
  • 36
    Dumois JA, VanderVegt FP, Kopp JB, Marinos NJ, Rooney JF, Notkins AL. Transplantation of skin from human immunodeficiency virus type 1-transgenic mice to normal congenic mice results in graft rejection. J Infect Dis 1995; 172: 232234.
  • 37
    Klinge H, Roopenian DC. The same genetic regions encode minor histocompatibility antigens detected in the context of different MHC haplotypes. Transplantation 1999; 67: 11781183.
  • 38
    Lu Z, Yuan L, Zhou X, Sotomayor E, Levitsky HI, Pardoll DM. CD40-independent pathways of T cell help for priming of CD8 (+) cytotoxic T lymphocytes. J Exp Med 2000; 191: 541550.
  • 39
    Marzo AL, Kinnear BF, Lake RA et al. Tumor-specific CD4+ T cells have a major ‘post-licensing' role in CTL mediated anti-tumor immunity. J Immunol 2000; 165: 60476055.
  • 40
    Kurts C, Carbone FR, Barnden M et al. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med 1997; 186: 20572062.
  • 41
    Kedl RM, Mescher MF. Migration and activation of antigen-specific CD8+ T cells upon in vivo stimulation with allogeneic tumor. J Immunol 1997; 159: 650663.
  • 42
    Shrikant P, Mescher MF. Control of syngeneic tumor growth by activation of CD8+ T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness. J Immunol 1999; 162: 28582866.
  • 43
    Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998; 393: 478480.
  • 44
    Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998; 393: 474478.
  • 45
    Schoenberger SP, Toes RE, Van Der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions. Nature 1998; 393: 480483.